Boston Scientific (BSX) Misses Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $43.72 +0.88%
Revenue Growth %: +2.6%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
MLKN, KBH, WOR, More
Revenue Growth %: +2.6%
Financial Fact:
Selling, general and administrative expenses: 772M
Today's EPS Names:
MLKN, KBH, WOR, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q3 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $3.17 billion versus the consensus estimate of $3.15 billion.
GUIDANCE:
Boston Scientific sees Q4 2022 EPS of $0.45-$0.48, versus the consensus of $0.49.
Boston Scientific sees FY2022 EPS of $1.71-$1.74, versus the consensus of $1.76.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- BofA Securities Starts PhysicsWallah Ltd (PWL:IN) at Underperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
